AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,576,643 | -1.9% | 211,895 | +1.3% | 0.02% | -8.7% |
| Q2 2023 | $2,627,288 | +64.4% | 209,179 | +36.7% | 0.02% | +53.3% |
| Q3 2022 | $1,598,000 | -10.5% | 153,069 | -7.9% | 0.02% | -11.8% |
| Q2 2022 | $1,785,000 | -34.5% | 166,197 | -42.3% | 0.02% | -43.3% |
| Q1 2022 | $2,725,000 | -26.8% | 287,796 | -10.8% | 0.03% | -28.6% |
| Q4 2021 | $3,725,000 | +19.4% | 322,468 | -1.3% | 0.04% | +40.0% |
| Q3 2021 | $3,120,000 | -7.1% | 326,710 | -6.2% | 0.03% | 0.0% |
| Q2 2021 | $3,359,000 | – | 348,441 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |